Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy

Background: Increasing evidence indicates a role for Epstein–Barr virus (EBV) in the pathogenesis of multiple sclerosis (MS). EBV-infected autoreactive B cells might accumulate in the central nervous system because of defective cytotoxic CD8(+) T cell immunity. We have previously reported results of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ioannides, Zara A., Csurhes, Peter A., Douglas, Nanette L., Mackenroth, Gem, Swayne, Andrew, Thompson, Kate M., Hopkins, Tracey J., Green, Kerryn A., Blum, Stefan, Hooper, Kaye D., Wyssusek, Kerstin H., Coulthard, Alan, Pender, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005645/
https://www.ncbi.nlm.nih.gov/pubmed/33790852
http://dx.doi.org/10.3389/fneur.2021.652811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005645/
https://www.ncbi.nlm.nih.gov/pubmed/33790852
http://dx.doi.org/10.3389/fneur.2021.652811

Ejemplares similares